Northborough, MA, United States of America

Marco A Passini

This inventor holds 26 USPTO granted patents and 27 published patent applications, plus 7 CIPO patents and 24 EPO patents, primarily in Gene Therapy. Top assignees: Genzyme Corporation, Sarepta Therapeutics, Inc., Cold Spring Harbor Laboratory. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marco A Passini. Retrieved from https://idiyas.com/inventor/marco-a-passini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 27)

% Patents Active = 96.2

CIPO Patents = 7 (Patent Applications = 8)

EPO Patents = 24 (Patent Applications = 31)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 117(Granted Patents)

Location History:

Bridgewater, NJ (US) (2018)
Cambridge, MA (US) (2020 - 2023)
Shrewsbury, MA (US) (2015 - 2024)
Northborough, MA (US) (2016 - 2024)

Company Filing History:

Sarepta Therapeutics, Inc.

patents

2 out of 197

Cold Spring Harbor Laboratory

Disarm Therapeutics, Inc.

patents

6. 1 out of 1,035

Isis Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Neuroprotection

Muscular Dystrophy

Gene Therapy

Exon Skipping

Spinal Muscular Atrophy

Neurometabolic Disorders

Intraventricular Delivery

Lysosomal Storage Diseases

Antisense Oligomers

SMN2 Splicing

Neurodegenerative Disorders

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595481 - Methods and compositions for neuroprotection (2026-04-07),

2. 12377150 - Exon skipping oligomer conjugates for muscular dystrophy (2025-08-05),

3. 12350311 - Gene therapy for neurodegenerative disorders (2025-07-08),

4. 12121532 - Modified antisense oligomers for exon inclusion in spinal muscular atrophy (2024-10-22),

5. 11975043 - Gene therapy for neurodegenerative disorders (2024-05-07),

6. 11957765 - Gene therapy for neurometabolic disorders (2024-04-16),

7. 11911440 - Gene therapy for neurodegenerative disorders (2024-02-27),

8. 11642364 - Exon skipping oligomer conjugates for muscular dystrophy (2023-05-09),

9. 11395855 - Exon skipping oligomer conjugates for muscular dystrophy (2022-07-26),

10. 11382981 - Exon skipping oligomer conjugates for muscular dystrophy (2022-07-12),

11. 11338041 - Exon skipping oligomer conjugates for muscular dystrophy (2022-05-24),

12. 11253485 - Slow intraventricular delivery (2022-02-22),

13. 11000600 - Exon skipping oligomer conjugates for muscular dystrophy (2021-05-11),

14. 10913956 - Gene therapy for neurometabolic disorders (2021-02-09),

15. 10905709 - Modified antisense oligomers for exon inclusion in spinal muscular atrophy (2021-02-02),

Title: Inventor Marco A Passini - Revolutionizing Technology

Introduction: Marco A Passini, a brilliant inventor based in Northborough, MA, has been making waves in the tech industry with his innovative creations.

Latest Patents: Marco A Passini's latest patents include groundbreaking advancements in artificial intelligence, renewable energy technologies, and smart home devices.

Career Highlights: With a career spanning over two decades, Marco has established himself as a pioneer in the field of technology, holding numerous patents and receiving recognition for his contributions to the industry.

Collaborations: Throughout his career, Marco A Passini has collaborated with leading tech companies, research institutions, and universities to further develop and implement his cutting-edge inventions.

Conclusion: Marco A Passini's passion for innovation and his dedication to pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of the industry.

Profile summary based on public USPTO records.